The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
How Much Larger Will The Siliq Market Become By 2030 Compared To 2026?
Historical growth can be linked to the increasing occurrence of moderate to severe plaque psoriasis, the limited effectiveness of traditional systemic therapies, a rise in dermatologists adopting biologics, the expansion of specialty dermatology clinics, and improved diagnostic rates.
The anticipated expansion throughout the forecast period stems from various factors, such as the increasing demand for next-generation biologics, a heightened emphasis on long-term disease management, the broadening scope of personalized immunology treatments, augmented investments in inflammatory disease research, and enhanced patient access to specialty therapies.
Prominent trends identified for the forecast period encompass the increasing adoption of targeted biologic therapies, the growing utilization of IL-17 pathway inhibitors, a rising concentration on personalized psoriasis treatment, the expansion of specialty pharmacy distribution channels, and improved monitoring of treatment outcomes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=20265&type=smp
What Market Drivers Are Helping Shape The Siliq Market Expansion?
The rising occurrence of skin conditions is expected to drive the expansion of the Siliq market in the future. Skin disease encompasses diverse ailments impacting the skin’s structure, performance, or look, frequently resulting from infections, inflammation, hereditary elements, autoimmune issues, or external factors. This uptick in skin disease cases stems from elements such as shifts in the environment, escalating pollution, greater sun exposure, genetic tendencies, and lifestyle aspects like inadequate nutrition and high stress. Siliq offers advantages for skin diseases, especially for moderate to severe plaque psoriasis, by targeting particular immune system pathways to diminish inflammation, enhance skin appearance, and relieve signs like redness, scaling, and itching. For example, in January 2024, the American Cancer Society, a US-based non-profit organization dedicated to eradicating cancer, forecast 108,270 documented cases of skin cancer, indicating a 3.2% rise from the 104,930 cases noted in 2023. Consequently, the heightened prevalence of skin disease is boosting the Siliq market’s development.
Siliq Market Driver: Rising Geriatric Demographics Fueling Demand For Siliq In Psoriasis Treatment
The expanding senior demographic is expected to propel the Siliq market’s growth. The geriatric population generally includes individuals aged 65 years or more, though this age criterion can differ based on context or health sector norms. The increase in the geriatric population results from longer life expectancies, improvements in medical care, and decreasing birth rates, leading to a greater share of older people worldwide. Siliq offers benefits for the elderly by providing an efficient treatment solution for moderate to severe plaque psoriasis, assisting in symptom management and enhancing skin health for older adults who might have fewer treatment choices due to age-related medical issues. As an illustration, in July 2024, figures from the UK Parliament’s House of Commons Library, a UK-based government administrative body, indicated that in 2022, the UK contained 12.7 million people aged 65 and above, constituting 19% of its total populace. By 2072, this figure is projected to rise to 22.1 million, or 27% of the population. Thus, the expanding geriatric population is fostering the growth of the Siliq market.
What Segment Categories Are Evaluated In The Siliq Market Study?
The siliq market covered in this report is segmented –
1) By Clinical Indication: Moderate To Severe Plaque Psoriasis, Other Indications
2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Specialty Pharmacies
3) By End-User: Hospitals, Specialty Clinics, Home Care Settings
Which Companies Form The Competitive Landscape Of The Siliq Market?
Major companies operating in the siliq market are Valeant Pharmaceuticals International Inc.
Access The Complete Siliq Market Report:
https://www.thebusinessresearchcompany.com/report/siliq-global-market-report
Which Region Leads The Siliq Market By Size?
North America was the largest region in the siliq market in 2025. North America is expected to be the fastest-growing region in the forecast period. The regions covered in the siliq market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model